L'Azienda Ospedaliero-Universitaria di Ferrara "Arcispedale Sant'Anna" è il più grande e importante ospedale di Ferrara e della sua provincia, nonché uno dei principali e maggiori policlinici dell'Emilia-Romagna.

During the past decade, Azienda Ospedaliero Universitaria di Ferrara conducted 107 clinical trials. In the 10-year time frame, 107 clinical trials started and 20 clinical trials were completed, i.e. on average, 18.7% percent of trials that started reached the finish line to date. In the past 5 years, 50 clinical trials started and 13 clinical trials were completed. i.e. 26% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Azienda Ospedaliero Universitaria di Ferrara" #1 sponsor was "University Hospital of Ferrara" with 27 trials, followed by "Università degli Studi di Ferrara" with 12 trials sponsored, "Boehringer Ingelheim" with 8 trials sponsored, "Bayer" with 7 trials sponsored and "University of Milano Bicocca" with 7 trials sponsored. Other sponsors include 75 different institutions and companies that sponsored additional 61 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda Ospedaliero Universitaria di Ferrara" #1 collaborator was "University of Padova" with 3 trials as a collaborator, "Università degli Studi di Ferrara" with 3 trials as a collaborator, "Aalborg University" with 2 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator and "Clinical Research Technology S.r.l." with 2 trials as a collaborator. Other collaborators include 63 different institutions and companies that were collaborators in the rest 71 trials.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliero Universitaria di Ferrara" are "Coronary Artery Disease" (9 trials), "Breast Cancer" (8 trials), "Heart Failure" (6 trials), "Atrial Fibrillation" (4 trials) and "Duchenne Muscular Dystrophy" (4 trials). Many other conditions were trialed in "Azienda Ospedaliero Universitaria di Ferrara" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliero Universitaria di Ferrara" are "Drug" (67 trials), "Other" (28 trials), "Device" (19 trials), "Procedure" (10 trials) and "Diagnostic Test" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Atezolizumab" (3 trials), "Paclitaxel" (3 trials), "Abemaciclib" (2 trials) and "Aromatase Inhibitors" (2 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliero Universitaria di Ferrara" are 121 trials for "All" genders, 13 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Azienda Ospedaliero Universitaria di Ferrara". undefined are not yet recruiting, 34 are recruiting, 20 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 74 completed trials in Azienda Ospedaliero Universitaria di Ferrara, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliero Universitaria di Ferrara, 1 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 27 trials that are defined as “Not Applicable".

Azienda Ospedaliero Universitaria di Ferrara has several departments that took part in Clinical trials: "Azienda Ospedaliera Universitaria Arcispedal, U.O. di Oncologia Clinica" - 4 trials